Table 2. Performances of the autoantibody EarlyCDT®-Lung test.
Cases | Controls | Sensitivity | Specificity | |
---|---|---|---|---|
Case-control studies | 235 | 266 | 41% | 91% |
Clinical audit dataset | 61 | 1,538 | 41% | 87% |
CT-detected lung nodules | 43 | 146 | 44% | 88% |
Cases | Controls | Sensitivity | Specificity | |
---|---|---|---|---|
Case-control studies | 235 | 266 | 41% | 91% |
Clinical audit dataset | 61 | 1,538 | 41% | 87% |
CT-detected lung nodules | 43 | 146 | 44% | 88% |